These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8502824)

  • 1. Long-term toxicity of tamoxifen.
    Rutqvist LE
    Recent Results Cancer Res; 1993; 127():257-66. PubMed ID: 8502824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen and secondary tumours. An update.
    Wilking N; Isaksson E; von Schoultz E
    Drug Saf; 1997 Feb; 16(2):104-17. PubMed ID: 9067122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis.
    Amir E; Seruga B; Niraula S; Carlsson L; Ocaña A
    J Natl Cancer Inst; 2011 Sep; 103(17):1299-309. PubMed ID: 21743022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual breast cancers followed by endometrial cancer.
    Dimitrievich E; Sterzinger A
    S D J Med; 2002 Jun; 55(6):227-9. PubMed ID: 12082808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial adenosarcoma with adjuvant tamoxifen therapy for primary breast carcinoma.
    Jagavkar RS; Shakespeare TP; Stevens MJ
    Australas Radiol; 1998 May; 42(2):157-8. PubMed ID: 9599835
    [No Abstract]   [Full Text] [Related]  

  • 6. Hysteroscopic follow-up in tamoxifen treatment for breast cancer.
    Litta P; Azzena A; Sandri A; Vasile C
    Clin Exp Obstet Gynecol; 1995; 22(1):47-51. PubMed ID: 7736642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between endometrial cancer and tamoxifen treatment of breast cancer.
    Peters-Engl C; Frank W; Danmayr E; Friedl HP; Leodolter S; Medl M
    Breast Cancer Res Treat; 1999 Apr; 54(3):255-60. PubMed ID: 10445424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term toxicity in adjuvant treatment with tamoxifen.
    Cobelli S; Dambrosio M; Farina G; Rovej R; Tomirotti M; Scanni A
    J Chemother; 1997 Aug; 9(4):300-3. PubMed ID: 9269612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: second cancers after adjuvant tamoxifen therapy for breast cancer.
    Rutqvist LE
    J Natl Cancer Inst; 1996 Oct; 88(20):1497-9; author reply, 1497-9. PubMed ID: 8841030
    [No Abstract]   [Full Text] [Related]  

  • 10. Iatrogenic endometrial megapolyps in women with breast carcinoma.
    Berezowsky J; Chalvardjian A; Murray D
    Obstet Gynecol; 1994 Oct; 84(4 Pt 2):727-30. PubMed ID: 9205466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Descriptive clinicopathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancer.
    Fornander T; Hellström AC; Moberger B
    J Natl Cancer Inst; 1993 Nov; 85(22):1850-5. PubMed ID: 8230266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen mediated human endometrial carcinogenesis may not involve estrogenic pathways: a preliminary note.
    Kuwashima Y; Kurosumi M; Kobayashi Y; Tanuma J; Suemasu K; Higashi Y; Kasamatsu T; Shiromizu K; Matsuzawa M; Kishi K
    Anticancer Res; 1996; 16(5A):2993-6. PubMed ID: 8917418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M; Kodama T
    In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.
    Love RR
    J Natl Cancer Inst; 1994 Jul; 86(13):1025-6. PubMed ID: 8007012
    [No Abstract]   [Full Text] [Related]  

  • 15. Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers.
    Cook LS; Weiss NS; Schwartz SM; White E; McKnight B; Moore DE; Daling JR
    J Natl Cancer Inst; 1995 Sep; 87(18):1359-64. PubMed ID: 7658496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic study of 56 patients with endometrial cancer during or after adjuvant tamoxifen use for their breast cancers.
    Hachisuga T; Saito T; Kigawa J; Ohwada M; Yamazawa K; Yasue A; Iwasaka T; Sugiyama T; Kita T; Nagai N
    Gynecol Oncol; 2004 Oct; 95(1):139-44. PubMed ID: 15385123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Breast cancer, tamoxifen, and uterus].
    Palacios A; Pertusa S; Montoya A; Martínez San Pedro R
    Med Clin (Barc); 1993 Mar; 100(12):479. PubMed ID: 8479228
    [No Abstract]   [Full Text] [Related]  

  • 18. The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma.
    Katase K; Sugiyama Y; Hasumi K; Yoshimoto M; Kasumi F
    Cancer; 1998 May; 82(9):1698-703. PubMed ID: 9576291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial mesodermal mixed tumor occurring after tamoxifen treatment: report on a new case and review of the literature.
    Dumortier J; Freyer G; Sasco AJ; Frappart L; Zénone T; Romestaing P; Trillet-Lenoir V
    Ann Oncol; 2000 Mar; 11(3):355-8. PubMed ID: 10811505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.
    Fisher B; Costantino JP; Redmond CK; Fisher ER; Wickerham DL; Cronin WM
    J Natl Cancer Inst; 1994 Apr; 86(7):527-37. PubMed ID: 8133536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.